Successful pregnancy outcome in a patient with myelofibrosis receiving ruxolitinib treatment in the first trimester

被引：0
|
作者：
Urosevic, Ivana [1 ,2 ]
Dokic, Marina [1 ,2 ]
Percic, Ivanka [1 ,2 ]
El Farra, Amir [1 ,2 ]
Bjelogrlic, Dunja [1 ]
Sekulic, Borivoj [1 ,2 ]
机构：
[1] Clin Ctr Vojvodina, Clin Hematol, Novi Sad, Serbia
[2] Univ Novi Sad, Med Fac, Dept Internal Med, Novi Sad 21000, Serbia
来源：
LEUKEMIA & LYMPHOMA | 2024年
关键词：
D O I：
10.1080/10428194.2024.2355558
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Successful outcome of pregnancy in a patient with Cushing's disease under treatment with ketoconazole during the first trimester of gestation
    Boronat, Mauro
    Marrero, Dunia
    Lopez-Plasencia, Yaiza
    Barber, Miguel
    Schamann, Yaiza
    Novoa, Francisco J.
    GYNECOLOGICAL ENDOCRINOLOGY, 2011, 27 (09) : 675 - 677
  • [2] Sustained Erythroid Response in a Patient with Myelofibrosis Receiving Concomitant Treatment with Ruxolitinib and Deferasirox
    Piro, Eugenio
    Lentini, Maria
    Levato, Luciano
    Russo, Antonio
    Molica, Stefano
    CHEMOTHERAPY, 2018, 63 (02) : 107 - 110
  • [3] Successful outcome of pregnancy in a patient with chronic myelogenous leukemia exposed to imatinib during the first trimester
    Suppiah, Revathi
    Kalaycio, Matt
    LEUKEMIA & LYMPHOMA, 2006, 47 (06) : 1149 - 1150
  • [4] Successful pregnancy outcome following first trimester pelvic inflammatory disease
    Stitely, ML
    Gherman, RB
    AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY, 2000, 40 (02): : 200 - 202
  • [5] Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis
    Tefferi, Ayalew
    Begna, Kebede
    Hogan, William J.
    Litzow, Mark R.
    Hanson, Curtis A.
    Pardanani, Animesh
    BLOOD, 2011, 118 (21) : 764 - 764
  • [6] Long-Term Outcome of Treatment with Ruxolitinib in Myelofibrosis
    Tefferi, Ayalew
    Litzow, Mark R.
    Pardanani, Animesh
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (15): : 1455 - 1457
  • [7] SUSTAINED ERYTHROPOIETIC RESPONSE IN A PATIENT WITH MYELOFIBROSIS RECEIVING CONCOMITANT RUXOLITINIB AND DEFERASIROX
    Piro, E.
    Kropp, M.
    Lentini, M.
    Levato, L.
    Magro, D.
    Molica, S.
    HAEMATOLOGICA, 2017, 102 : 97 - 97
  • [8] Successful ruxolitinib rechallenge after fedratinib failure in a patient with overt myelofibrosis
    Pinczes, Laszlo Imre
    Jona, Adam
    Mezei, Gabriella
    Kenyeres, Anna
    Vekszler, Peter Pambo
    Illes, Arpad
    Simon, Zsofia
    ANNALS OF HEMATOLOGY, 2024, : 4817 - 4819
  • [9] Ruxolitinib: The First FDA Approved Therapy for the Treatment of Myelofibrosis
    Mascarenhas, John
    Hoffman, Ronald
    CLINICAL CANCER RESEARCH, 2012, 18 (11) : 3008 - 3014
  • [10] Ruxolitinib for the Treatment of Portal Hypertension in a Patient With Primary Myelofibrosis
    Tan, Hiang Keat
    Leow, Wei Qiang
    Chang, Pik Eu
    GASTROENTEROLOGY, 2019, 157 (05) : E26 - E27
12345